Jan Van den Bossche Lab
@immunometlab
We study macrophages! We aim to understand and reshape macrophage immunometabolism to improve function and disease outcome. 🧫🔬🥼🧑🔬 🦠🧑💻🏥 #playforward
The abstract submission for the 2025 EMDS meeting in Edinburgh is open: emds2025.com I very much look forward to this conference and finally visiting Schotland for the first time 😍
Spreading the macrophages love for 🎄 🎅 🎁 in @immunometlab
I’m looking forward to contribute to the immunometabolism part at the NVVI @DsiNvvi spring symposium in Lunteren next year
NVVI spring symposium goes BACK TO THE ROOTS. Or forward to immunometabolism? I spotted at least 5/6 (immuno)metabolism talks @DsiNvvi. Do you join us?
Superb study of the effect of Trypanosomiasis infection on Kupffer cell function even weeks after cure and elimination of the parasite. Beautiful work from Jo Van Ginderachter and @MovahediTeam labs #EMDS2024. 🤩🤩🤩🤩🤩
Joining 🦋 @martinguilliams.bsky.social Let’s see if we can #EMDS2024 Vienna #macrophage and #dendriticcell fans there!
Supported by @ImmunoMetEurope, @ImmunoMetNet, @BSI_immunomet, @ImmunoMet @immunemet, @SocietyEuropean and others working on immunometabolism, the aim of the Immunometabolism journal @Immunometaboli2 is to further grow and to become THE go-to journal in this exciting field
Our journal welcomes short commentary articles to put recently published high-impact work in a broader perspective. 🥳🥳🥳Interests in writing a commentary, contact our EiC Professor Jan Van den Bossche @immunometlab and the EB member Professor Sarah Dimeloe @SarahDimeloeLab
A potential immunometabolic effect of antidepressant drug SSRI❔⬇️
Our journal welcomes short commentary articles to put recently published high-impact work in a broader perspective. 🥳🥳🥳Interests in writing a commentary, contact our EiC Professor Jan Van den Bossche @immunometlab and the EB member Professor Sarah Dimeloe @SarahDimeloeLab
Next-generation immunotherapy opportunities using “T-linker” ⬇️
A linker-based platform integrates multiple therapeutic modules into a single ‘Multi-TAC’, which can engage multiple tumor-targeting immune cells within the tumor microenvironment cell.com/cell/fulltext/… #NBThighlight
📢Last weeks #immunometabolism discoveries @Bims_BiomedNews 👇👇👇 biomed.news/bims-imicid/20… Highlights: I) CENCAT - a new tool for probing immune cell metabolic states II) Cholesterol synthesis drives the SASP and neurotoxicity in a patient stem cell-derived model of MS
CENCAT; an immunometabolic profiling tool that blends the @SCENITHmetab approach with BONCAT click chemistry to measure metabolic dependencies of cell subsets @CellRepMethods paper online now ➡️ cell.com/cell-reports-m…
📢Last weeks #immunometabolism discoveries @Bims_BiomedNews 👇👇👇 biomed.news/bims-imicid/20… It's a big one this week, check it out!
A timeless model for writing a research summary.
No time for daily physical activity during your busy work week? No problem! This @NatureAging paper shows that a “weekend warrior pattern” yields similar brain health benefits 💪🏼 🏃🏻♂️ 🚲 🧠 nature.com/articles/s4358…
Immunometabolism journal (@Immunometaboli2) welcomes short commentary articles to put recently published high-impact work in a broader perspective. Please share and reach out if you want to contribute an #immunometabolism (short) article like @WeichhartLab just did 🤗
Check out Thomas Weichhart et al's comments on this paper journals.lww.com/immunometaboli… Check out Thomas Weichhart et al's comments on this paper @immunometlab @SocietyEuropean @ImmunoMetNet